Logo-bi
Bioimpacts. 2013;3(4): 199-200. doi: 10.5681/bi.2013.033
PMID: 24455484        PMCID: PMC3892740

Commentary

Commentary on: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy

Viroj Wiwanitkit 1,2,3 *

Cited by CrossRef: 0




As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge